Biognosys' Convertible Note Round

Biognosys raised a round of funding on January 10, 2014.

Biognosys is a provider in targeted proteomics and at the forefront of personalized healthcare development. The company's new generation of proteomics – targeted proteomics - can quantify proteins f…

Articles about Biognosys' Convertible Note Round: